Literature DB >> 35474050

Molecular mechanism of microRNAs regulating apoptosis in osteosarcoma.

Xueyang Cai1, Wei Yin1, Chao Tang1, Yubao Lu2, Yuqi He3.   

Abstract

Osteosarcoma is a primary malignant bone tumor with no effective treatment. Apoptosis, one of the programmed cell death, is any pathological form of cell death mediated by intracellular processes. Under the pathological state, the de-regulated regulation of apoptosis can disrupt the balance between cell proliferation and death, causing osteosarcoma proliferation and metastasis. As carcinogenic or tumor suppressor factors, microRNAs (miRNAs) regulate apoptosis of osteosarcoma cells by regulating apoptosis-related genes and apoptosis-related signaling pathways, such as mitochondrial apoptosis pathway, death receptor pathway, and endoplasmic reticulum pathway. Meanwhile as these abnormal miRNAs can be stored and transported by exosomes, detecting exosomes can be seen an effective method to diagnose osteosarcoma in the early stage. This review provides the current knowledge of miRNAs and their target genes related to the apoptosis of osteosarcoma, summarizes abnormal expression and regulation of miRNAs and signaling pathways in osteosarcoma and prospects the detection of exosome as a method for early diagnosis of osteosarcoma.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Apoptosis; Mitochondria; Osteosarcoma; microRNAs

Mesh:

Substances:

Year:  2022        PMID: 35474050     DOI: 10.1007/s11033-022-07344-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  82 in total

1.  MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5.

Authors:  D-Z Wang; S-F Jing; S-B Hao; X-Y Huang; Q-T Miao; J-F Gao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-10       Impact factor: 3.507

2.  miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.

Authors:  Jie Chen; Jinsong Zhou; Xin Chen; Baohui Yang; Dong Wang; Pinglin Yang; Xijing He; Haopeng Li
Journal:  Tumour Biol       Date:  2015-05-23

3.  International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Int J Cancer       Date:  2009-07-01       Impact factor: 7.396

Review 4.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

5.  Identification of Differentially Expressed MicroRNAs in Osteosarcoma.

Authors:  Rishi R Lulla; Fabricio F Costa; Jared M Bischof; Pauline M Chou; Maria de F Bonaldo; Elio F Vanin; Marcelo B Soares
Journal:  Sarcoma       Date:  2011-07-18

6.  miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma.

Authors:  Wei Xu; Zhikun Li; Xiaodong Zhu; Ruijun Xu; Youjia Xu
Journal:  Med Sci Monit       Date:  2018-12-06

7.  miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma.

Authors:  Lijun Yu; Min Meng; Yun Bao; Chao Zhang; Bei Gao; Rina Sa; Wenyuan Luo
Journal:  Yonsei Med J       Date:  2019-09       Impact factor: 2.759

8.  Influence mechanism of miRNA-144 on proliferation and apoptosis of osteosarcoma cells.

Authors:  Xu Zhang; Zhengwei Li; Wei Ji; Xilong Chen; Qiang Gao; Dajin Li; Haihui Qin
Journal:  Oncol Lett       Date:  2019-12-10       Impact factor: 2.967

9.  Thiostrepton and miR-216b synergistically promote osteosarcoma cell cytotoxicity and apoptosis by targeting FoxM1.

Authors:  Xiaobing Cai; Wenyu Xiao; Juexin Shen; Hui Lian; Yi Lu; Xianmiao Liu; Jisheng Gu
Journal:  Oncol Lett       Date:  2020-10-29       Impact factor: 2.967

10.  Signature of circulating microRNAs in osteoarthritis.

Authors:  Christian Beyer; Anna Zampetaki; Neng-Yu Lin; Arnd Kleyer; Carlo Perricone; Annamaria Iagnocco; Alfiya Distler; Sarah R Langley; Kolja Gelse; Stefan Sesselmann; Rolando Lorenzini; Andreas Niemeier; Bernd Swoboda; Jörg H W Distler; Peter Santer; Georg Egger; Johann Willeit; Manuel Mayr; Georg Schett; Stefan Kiechl
Journal:  Ann Rheum Dis       Date:  2014-02-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.